Silmitasertib plus gemcitabine and cisplatin first-line therapy in locally advanced/metastatic cholangiocarcinoma: A Phase 1b/2 study.
Hepatology
; 77(3): 760-773, 2023 03 01.
Article
in En
| MEDLINE
| ID: mdl-36152015
Full text:
1
Database:
MEDLINE
Main subject:
Bile Duct Neoplasms
/
Cholangiocarcinoma
Limits:
Humans
Language:
En
Journal:
Hepatology
Year:
2023
Type:
Article
Affiliation country:
United States